• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. SYRINGE 5ML LS 22X1-1/4 AN EMERALD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. SYRINGE 5ML LS 22X1-1/4 AN EMERALD Back to Search Results
Catalog Number 30773319
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Needle Stick/Puncture (2462)
Event Date 03/29/2021
Event Type  Injury  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that syringe 5ml ls 22x1-1/4 an emerald was used and the person received a clean needle stick, but is undergoing a series of inspections for infectious diseases.The following information was provided by the initial reporter: the distributor reported that bibao's 5ml product was used in the (b)(6) cancer hospital-department of hematology.When the product package was opened, the medical staff (nurse) was injured by needle sticks due to the missing needle shield.Hospital requirements: all products of the same batch need to be withdrawn from the hospital; injured personnel must undergo a series of inspections for infectious diseases; bd is required to write a rectification report (how the manufacturer handles this situation) and need to be submitted tomorrow; the distributor stated that this is the second time the problem occurred with the 5ml product, and the hospital stated that if it occurs for the third time, the hospital will no longer use the product.
 
Manufacturer Narrative
H6: investigation summary a device history record review was completed for provided lot number 1902122.The review did not reveal any detected abnormalities during the production process that could have contributed to the reported defects and all quality tests were found to be within specification.To aid in the investigation of this issue, picture and physical samples were returned for evaluation by our quality engineer team.Through examination of the samples, the syringe was observed packaged without the needle shield.It has been concluded that the shields were lost during the packaging process due to low fitting force.If the shield is not properly assembled, as the needles moves through the feeder mechanism of the packaging machine, the shield may become detached.To avoid this situation, a needle length detector is set up to reject any product that does not reach a specified distance.For this instance, the faulty product went undetected.The detection system is allocated in the primary packaging machine and inspects one hundred percent of product.The detection system is positioned to detect the absence of product in the cavity, if no needle is attached to the syringe, and if there is no needle shield attached.The accuracy for the no-needle detection is very high (one hundred percent effectivity), but in the case of accuracy for the no needle-shield detection, it can be much more difficult to identify.The system is challenged every 8 hours and our quality team is continuously trying to improve the detection system for identifying needle shield absence.Upon receiving this report for lot 1902122, the production line used was reviewed and it was confirmed that the production line currently has the capability to detect needles without shields.
 
Event Description
It was reported that syringe 5ml ls 22x1-1/4 an emerald was used and the person received a clean needle stick, but is undergoing a series of inspections for infectious diseases.The following information was provided by the initial reporter: 1.The distributor reported that bibao's 5ml product was used in the sixth ward of henan cancer hospital-department of hematology.When the product package was opened, the medical staff (nurse) was injured by needle sticks due to the missing needle shield.2.Hospital requirements: (1) all products of the same batch need to be withdrawn from the hospital; (2) injured personnel must undergo a series of inspections for infectious diseases; (3) bd is required to write a rectification report (how the manufacturer handles this situation) and need to be submitted tomorrow (4) the distributor stated that this is the second time the problem occurred with the 5ml product, and the hospital stated that if it occurs for the third time, the hospital will no longer use the product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYRINGE 5ML LS 22X1-1/4 AN EMERALD
Type of Device
SYRINGE
Manufacturer (Section D)
BECTON DICKINSON, S.A.
cr mequinenza
s/n
fraga, huesca 22520
SP  22520
MDR Report Key11729710
MDR Text Key262528576
Report Number3002682307-2021-00154
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 05/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date01/31/2024
Device Catalogue Number30773319
Device Lot Number1902122
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/12/2021
Date Manufacturer Received05/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-